According to this latest study, the 2021 growth of Intravenous Immunoglobulin (IVIg) will have significant change from previous year. By the most conservative estimates of global Intravenous Immunoglobulin (IVIg) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 9523.6 million in 2020. Over the next five years the Intravenous Immunoglobulin (IVIg) market will register a 6.1% CAGR in terms of revenue, the global market size will reach US$ 12080 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Immunoglobulin (IVIg) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
IVIg Liquid
IVIg Powder
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Immunodeficiency
Autoimmune Disease
Acute Infection
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravenous Immunoglobulin (IVIg) Consumption 2016-2026
2.1.2 Intravenous Immunoglobulin (IVIg) Consumption CAGR by Region
2.2 Intravenous Immunoglobulin (IVIg) Segment by Type
2.2.1 IVIg Liquid
2.2.2 IVIg Powder
2.3 Intravenous Immunoglobulin (IVIg) Sales by Type
2.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
2.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2016-2021)
2.3.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Type (2016-2021)
2.4 Intravenous Immunoglobulin (IVIg) Segment by Application
2.4.1 Immunodeficiency
2.4.2 Autoimmune Disease
2.4.3 Acute Infection
2.5 Intravenous Immunoglobulin (IVIg) Sales by Application
2.5.1 Global Intravenous Immunoglobulin (IVIg) Sale Market Share by Application (2016-2021)
2.5.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Application (2016-2021)
2.5.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Application (2016-2021)
3 Global Intravenous Immunoglobulin (IVIg) by Company
3.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company
3.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Company (2019-2021)
3.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2019-2021)
3.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company
3.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Company (2019-2021)
3.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2019-2021)
3.3 Global Intravenous Immunoglobulin (IVIg) Sale Price by Company
3.4 Global Manufacturers Intravenous Immunoglobulin (IVIg) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous Immunoglobulin (IVIg) Product Location Distribution
3.4.2 Players Intravenous Immunoglobulin (IVIg) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Intravenous Immunoglobulin (IVIg) by Region
4.1 Global Intravenous Immunoglobulin (IVIg) by Region
4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region
4.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Region
4.2 Americas Intravenous Immunoglobulin (IVIg) Sales Growth
4.3 APAC Intravenous Immunoglobulin (IVIg) Sales Growth
4.4 Europe Intravenous Immunoglobulin (IVIg) Sales Growth
4.5 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Growth
5 Americas
5.1 Americas Intravenous Immunoglobulin (IVIg) Sales by Country
5.1.1 Americas Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021)
5.1.2 Americas Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021)
5.2 Americas Intravenous Immunoglobulin (IVIg) Sales by Type
5.3 Americas Intravenous Immunoglobulin (IVIg) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous Immunoglobulin (IVIg) Sales by Region
6.1.1 APAC Intravenous Immunoglobulin (IVIg) Sales by Region (2016-2021)
6.1.2 APAC Intravenous Immunoglobulin (IVIg) Revenue by Region (2016-2021)
6.2 APAC Intravenous Immunoglobulin (IVIg) Sales by Type
6.3 APAC Intravenous Immunoglobulin (IVIg) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Intravenous Immunoglobulin (IVIg) by Country
7.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021)
7.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021)
7.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Type
7.3 Europe Intravenous Immunoglobulin (IVIg) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) by Country
8.1.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021)
8.1.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021)
8.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Type
8.3 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Intravenous Immunoglobulin (IVIg) Distributors
10.3 Intravenous Immunoglobulin (IVIg) Customer
11 Global Intravenous Immunoglobulin (IVIg) Market Forecast
11.1 Global Intravenous Immunoglobulin (IVIg) Forecast by Region
11.1.1 Global Intravenous Immunoglobulin (IVIg) Forecast by Regions (2021-2026)
11.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Intravenous Immunoglobulin (IVIg) Forecast by Type
11.7 Global Intravenous Immunoglobulin (IVIg) Forecast by Application
12 Key Players Analysis
12.1 Baxter
12.1.1 Baxter Company Information
12.1.2 Baxter Intravenous Immunoglobulin (IVIg) Product Offered
12.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Baxter Main Business Overview
12.1.5 Baxter Latest Developments
12.2 Grifols
12.2.1 Grifols Company Information
12.2.2 Grifols Intravenous Immunoglobulin (IVIg) Product Offered
12.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Grifols Main Business Overview
12.2.5 Grifols Latest Developments
12.3 CSL
12.3.1 CSL Company Information
12.3.2 CSL Intravenous Immunoglobulin (IVIg) Product Offered
12.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 CSL Main Business Overview
12.3.5 CSL Latest Developments
12.4 Octapharma
12.4.1 Octapharma Company Information
12.4.2 Octapharma Intravenous Immunoglobulin (IVIg) Product Offered
12.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Octapharma Main Business Overview
12.4.5 Octapharma Latest Developments
12.5 Biotest
12.5.1 Biotest Company Information
12.5.2 Biotest Intravenous Immunoglobulin (IVIg) Product Offered
12.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Biotest Main Business Overview
12.5.5 Biotest Latest Developments
12.6 Kedrion
12.6.1 Kedrion Company Information
12.6.2 Kedrion Intravenous Immunoglobulin (IVIg) Product Offered
12.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Kedrion Main Business Overview
12.6.5 Kedrion Latest Developments
12.7 Hualan Bio
12.7.1 Hualan Bio Company Information
12.7.2 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Offered
12.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Hualan Bio Main Business Overview
12.7.5 Hualan Bio Latest Developments
12.8 CNBG
12.8.1 CNBG Company Information
12.8.2 CNBG Intravenous Immunoglobulin (IVIg) Product Offered
12.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 CNBG Main Business Overview
12.8.5 CNBG Latest Developments
12.9 Shanghai RAAS
12.9.1 Shanghai RAAS Company Information
12.9.2 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Offered
12.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Shanghai RAAS Main Business Overview
12.9.5 Shanghai RAAS Latest Developments
12.10 CBPO
12.10.1 CBPO Company Information
12.10.2 CBPO Intravenous Immunoglobulin (IVIg) Product Offered
12.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 CBPO Main Business Overview
12.10.5 CBPO Latest Developments
12.11 LFB Group
12.11.1 LFB Group Company Information
12.11.2 LFB Group Intravenous Immunoglobulin (IVIg) Product Offered
12.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 LFB Group Main Business Overview
12.11.5 LFB Group Latest Developments
12.12 BPL
12.12.1 BPL Company Information
12.12.2 BPL Intravenous Immunoglobulin (IVIg) Product Offered
12.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 BPL Main Business Overview
12.12.5 BPL Latest Developments
12.13 Sichuan Yuanda Shuyang
12.13.1 Sichuan Yuanda Shuyang Company Information
12.13.2 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Offered
12.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Sichuan Yuanda Shuyang Main Business Overview
12.13.5 Sichuan Yuanda Shuyang Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Intravenous Immunoglobulin (IVIg) Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of IVIg Liquid
Table 3. Major Players of IVIg Powder
Table 4. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 5. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 6. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2016-2021) & ($ million)
Table 7. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2016-2021)
Table 8. Global Intravenous Immunoglobulin (IVIg) Sale Price by Type (2016-2021)
Table 9. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 10. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 11. Global Intravenous Immunoglobulin (IVIg) Value by Application (2016-2021)
Table 12. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2016-2021)
Table 13. Global Intravenous Immunoglobulin (IVIg) Sale Price by Application (2016-2021)
Table 14. Global Intravenous Immunoglobulin (IVIg) Sales by Company (2019-2021) & (K Bottle)
Table 15. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2019-2021)
Table 16. Global Intravenous Immunoglobulin (IVIg) Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2019-2021)
Table 18. Global Intravenous Immunoglobulin (IVIg) Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Intravenous Immunoglobulin (IVIg) Producing Area Distribution and Sales Area
Table 20. Players Intravenous Immunoglobulin (IVIg) Products Offered
Table 21. Intravenous Immunoglobulin (IVIg) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2016-2021) (K Bottle)
Table 25. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)
Table 26. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2016-2021)
Table 28. Americas Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 29. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)
Table 30. Americas Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)
Table 32. Americas Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 33. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 34. Americas Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 35. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 36. APAC Intravenous Immunoglobulin (IVIg) Sales by Region (2016-2021) & (K Bottle)
Table 37. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)
Table 38. APAC Intravenous Immunoglobulin (IVIg) Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2016-2021)
Table 40. APAC Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 41. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 42. APAC Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 43. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 44. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 45. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)
Table 46. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)
Table 48. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 49. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 50. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 51. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 53. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 57. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 59. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Intravenous Immunoglobulin (IVIg)
Table 61. Key Application and Potential Industries of Intravenous Immunoglobulin (IVIg)
Table 62. Key Challenges of Intravenous Immunoglobulin (IVIg)
Table 63. Key Trends of Intravenous Immunoglobulin (IVIg)
Table 64. Intravenous Immunoglobulin (IVIg) Distributors List
Table 65. Intravenous Immunoglobulin (IVIg) Customer List
Table 66. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2021-2026) & (K Bottle)
Table 67. Global Intravenous Immunoglobulin (IVIg) Consumption Market Forecast by Region
Table 68. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2021-2026) & (K Bottle)
Table 71. Americas Intravenous Immunoglobulin (IVIg) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2021-2026) & (K Bottle)
Table 73. APAC Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2021-2026) & (K Bottle)
Table 75. Europe Intravenous Immunoglobulin (IVIg) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2021-2026) & (K Bottle)
Table 77. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2021-2026) & (K Bottle)
Table 79. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2021-2026) & (K Bottle)
Table 83. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Application (2021-2026)
Table 86. Baxter Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 87. Baxter Intravenous Immunoglobulin (IVIg) Product Offered
Table 88. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 89. Baxter Main Business
Table 90. Baxter Latest Developments
Table 91. Grifols Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 92. Grifols Intravenous Immunoglobulin (IVIg) Product Offered
Table 93. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 94. Grifols Main Business
Table 95. Grifols Latest Developments
Table 96. CSL Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 97. CSL Intravenous Immunoglobulin (IVIg) Product Offered
Table 98. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 99. CSL Main Business
Table 100. CSL Latest Developments
Table 101. Octapharma Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 102. Octapharma Intravenous Immunoglobulin (IVIg) Product Offered
Table 103. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 104. Octapharma Main Business
Table 105. Octapharma Latest Developments
Table 106. Biotest Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 107. Biotest Intravenous Immunoglobulin (IVIg) Product Offered
Table 108. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 109. Biotest Main Business
Table 110. Biotest Latest Developments
Table 111. Kedrion Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 112. Kedrion Intravenous Immunoglobulin (IVIg) Product Offered
Table 113. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 114. Kedrion Main Business
Table 115. Kedrion Latest Developments
Table 116. Hualan Bio Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 117. Hualan Bio Intravenous Immunoglobulin (IVIg) Product Offered
Table 118. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 119. Hualan Bio Main Business
Table 120. Hualan Bio Latest Developments
Table 121. CNBG Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 122. CNBG Intravenous Immunoglobulin (IVIg) Product Offered
Table 123. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 124. CNBG Main Business
Table 125. CNBG Latest Developments
Table 126. Shanghai RAAS Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 127. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Offered
Table 128. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 129. Shanghai RAAS Main Business
Table 130. Shanghai RAAS Latest Developments
Table 131. CBPO Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 132. CBPO Intravenous Immunoglobulin (IVIg) Product Offered
Table 133. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 134. CBPO Main Business
Table 135. CBPO Latest Developments
Table 136. LFB Group Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 137. LFB Group Intravenous Immunoglobulin (IVIg) Product Offered
Table 138. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 139. LFB Group Main Business
Table 140. LFB Group Latest Developments
Table 141. BPL Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 142. BPL Intravenous Immunoglobulin (IVIg) Product Offered
Table 143. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 144. BPL Main Business
Table 145. BPL Latest Developments
Table 146. Sichuan Yuanda Shuyang Basic Information, Intravenous Immunoglobulin (IVIg) Manufacturing Base, Sales Area and Its Competitors
Table 147. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Offered
Table 148. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2019-2021E)
Table 149. Sichuan Yuanda Shuyang Main Business
Table 150. Sichuan Yuanda Shuyang Latest Developments
List of Figures
Figure 1. Picture of Intravenous Immunoglobulin (IVIg)
Figure 2. Intravenous Immunoglobulin (IVIg) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate 2016-2026 (K Bottle)
Figure 7. Global Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Intravenous Immunoglobulin (IVIg) Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of IVIg Liquid
Figure 10. Product Picture of IVIg Powder
Figure 11. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020
Figure 12. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2016-2021)
Figure 13. Intravenous Immunoglobulin (IVIg) Consumed in Immunodeficiency
Figure 14. Global Intravenous Immunoglobulin (IVIg) Market: Immunodeficiency (2016-2021) & (K Bottle)
Figure 15. Intravenous Immunoglobulin (IVIg) Consumed in Autoimmune Disease
Figure 16. Global Intravenous Immunoglobulin (IVIg) Market: Autoimmune Disease (2016-2021) & (K Bottle)
Figure 17. Intravenous Immunoglobulin (IVIg) Consumed in Acute Infection
Figure 18. Global Intravenous Immunoglobulin (IVIg) Market: Acute Infection (2016-2021) & (K Bottle)
Figure 19. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Figure 20. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application in 2020
Figure 21. Intravenous Immunoglobulin (IVIg) Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company in 2020
Figure 23. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions (2016-2021)
Figure 24. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region in 2020
Figure 25. Americas Intravenous Immunoglobulin (IVIg) Sales 2016-2021 (K Bottle)
Figure 26. Americas Intravenous Immunoglobulin (IVIg) Revenue 2016-2021 ($ Millions)
Figure 27. APAC Intravenous Immunoglobulin (IVIg) Sales 2016-2021 (K Bottle)
Figure 28. APAC Intravenous Immunoglobulin (IVIg) Revenue 2016-2021 ($ Millions)
Figure 29. Europe Intravenous Immunoglobulin (IVIg) Sales 2016-2021 (K Bottle)
Figure 30. Europe Intravenous Immunoglobulin (IVIg) Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales 2016-2021 (K Bottle)
Figure 32. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue 2016-2021 ($ Millions)
Figure 33. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2020
Figure 34. Americas Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country in 2020
Figure 35. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020
Figure 36. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020
Figure 37. United States Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Region in 2020
Figure 42. APAC Intravenous Immunoglobulin (IVIg) Revenue Market Share by Regions in 2020
Figure 43. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020
Figure 44. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020
Figure 45. China Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2020
Figure 52. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country in 2020
Figure 53. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020
Figure 54. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020
Figure 55. Germany Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020
Figure 64. Egypt Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Intravenous Immunoglobulin (IVIg) Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles